March 5, 2021 | COVID-19 | 0 comments | Author: Diane Weiss
The Centers for Disease Control (CDC), American Academy of Pediatrics (AAP), and the state of Florida have expanded COVID 19 vaccine availability to certain High Risk adolescent individuals 16 years of age and older.
In our continuing efforts to keep our patients safe during this pandemic, upon request we will complete the necessary form for all children that meet the criteria so that they may receive the vaccine when and if it is available.
This ONLY applies to the Pfizer vaccine* at present. It is the only company with a COVID-19 vaccine approved for ages 16 and up by the FDA. Other companies are petitioning for inclusion but are not covered by this new recommendation.
Weiss Pediatric Care adhere closely to the definition of High Risk as outlined by the Centers for Disease Control. The conditions that are accepted as fulfilling the approval for Pfizer COVID 19 SARS Vaccine are as follows:
These rigid criteria are due to the lack of significant safety data to allow the blanket approval for all children that will hopefully come prior to next school year (2021-2022). This is an emergency approval granted by the FDA and approved by the CDC and AAP at this time.
Weiss Pediatric Care will update this guidance as new information is made available by CDC, FDA, and the AAP.